Bulletin
Investor Alert
×

CareDx Inc.

NAS: CDNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 17, 2019, 7:45 p.m.

/zigman2/quotes/200138382/composite

$

31.06

Change

+0.10 +0.32%

Volume

Volume 3,139

Quotes are delayed by 20 min

/zigman2/quotes/200138382/composite

Previous close

$ 32.57

$ 30.96

Change

-1.61 -4.94%

Day low

Day high

$30.65

$33.24

Open

52 week low

52 week high

$11.93

$41.27

Open

Insider Actions for CareDx Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $5.02 per share. 26,380
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $5.85 per share. 30,741
07/11/2019 Fred E. Cohen
Director
5,255   Derivative/Non-derivative trans. at $10 per share. 52,550
07/01/2019 George W. Bickerstaff
Director
468   Award at $0 per share. 0
07/01/2019 Michael D. Goldberg
Director
734   Award at $0 per share. 0
07/01/2019 Ralph D. Snyderman
Director
312   Award at $0 per share. 0
07/01/2019 Grace E. Colón
Director
4,181   Award at $0 per share. 0
07/01/2019 Sasha King
Chief Commercial Officer
250   Derivative/Non-derivative trans. at $1 per share. 250
07/01/2019 James P. Yee
Chief Medical Officer
19,875   Derivative/Non-derivative trans. at $2.3 per share. 45,712
07/01/2019 Sasha King
Chief Commercial Officer
9,542   Disposition at $35.74 per share. 341,031
07/01/2019 James P. Yee
Chief Medical Officer
20,000   Disposition at $35.65 per share. 713,000
06/20/2019 Michael Bell
Chief Financial Officer
14,702   Disposition at $38.81 per share. 570,584
06/20/2019 Sasha King
Chief Commercial Officer
30,840   Disposition at $38.38 per share. 1,183,639
06/20/2019 Michael Bell
Chief Financial Officer
12,500   Derivative/Non-derivative trans. at $12.24 per share. 153,000
06/20/2019 Michael Bell
Chief Financial Officer
292   Derivative/Non-derivative trans. at $6.31 per share. 1,842
06/20/2019 Michael Bell
Chief Financial Officer
937   Derivative/Non-derivative trans. at $5.9 per share. 5,528
06/20/2019 Michael Bell
Chief Financial Officer
139   Derivative/Non-derivative trans. at $2.8 per share. 389
06/20/2019 Michael Bell
Chief Financial Officer
834   Derivative/Non-derivative trans. at $1 per share. 834
06/20/2019 Sasha King
Chief Commercial Officer
12,500   Derivative/Non-derivative trans. at $12.24 per share. 153,000
06/20/2019 Sasha King
Chief Commercial Officer
833   Derivative/Non-derivative trans. at $6.31 per share. 5,256
06/20/2019 Sasha King
Chief Commercial Officer
1,667   Derivative/Non-derivative trans. at $5.9 per share. 9,835
06/20/2019 Sasha King
Chief Commercial Officer
278   Derivative/Non-derivative trans. at $2.8 per share. 778
06/20/2019 Sasha King
Chief Commercial Officer
417   Derivative/Non-derivative trans. at $1.07 per share. 446
06/20/2019 Sasha King
Chief Commercial Officer
500   Derivative/Non-derivative trans. at $1 per share. 500
06/17/2019 George W. Bickerstaff
Director
2,613   Award at $0 per share. 0
06/17/2019 Michael D. Goldberg
Director
2,613   Award at $0 per share. 0
06/17/2019 Fred E. Cohen
Director
2,613   Award at $0 per share. 0
06/17/2019 Ralph D. Snyderman
Director
2,613   Award at $0 per share. 0
06/17/2019 William A. Hagstrom
Director
2,613   Award at $0 per share. 0
06/17/2019 James P. Yee
Chief Medical Officer
20,000   Derivative/Non-derivative trans. at $6.49 per share. 129,800
06/17/2019 James P. Yee
Chief Medical Officer
20,000   Disposition at $37.54 per share. 750,800
06/04/2019 William A. Hagstrom
Director
15,000   Disposition at $32.35 per share. 485,250
06/03/2019 Peter K. Maag
Chief Executive Officer; Director
18,592   Derivative/Non-derivative trans. at $32.8 per share. 609,817
06/03/2019 Michael Bell
Chief Financial Officer
6,197   Derivative/Non-derivative trans. at $32.8 per share. 203,261
06/03/2019 Sasha King
Chief Commercial Officer
4,322   Derivative/Non-derivative trans. at $32.8 per share. 141,761
06/03/2019 James P. Yee
Chief Medical Officer
1,239   Derivative/Non-derivative trans. at $32.8 per share. 40,639
05/20/2019 Michael Bell
Chief Financial Officer
2,202   Disposition at $32.1 per share. 70,684
05/20/2019 Michael Bell
Chief Financial Officer
292   Derivative/Non-derivative trans. at $6.31 per share. 1,842
05/20/2019 Michael Bell
Chief Financial Officer
938   Derivative/Non-derivative trans. at $5.9 per share. 5,534
05/20/2019 Michael Bell
Chief Financial Officer
139   Derivative/Non-derivative trans. at $2.8 per share. 389
05/20/2019 Michael Bell
Chief Financial Officer
833   Derivative/Non-derivative trans. at $1 per share. 833
05/13/2019 Peter K. Maag
Chief Executive Officer; Director
80,000   Disposition at $31.11 per share. 2,488,800
05/09/2019 Michael Bell
Chief Financial Officer
14,894   Disposition at $32.42 per share. 482,863
05/09/2019 Michael Bell
Chief Financial Officer
292   Derivative/Non-derivative trans. at $6.31 per share. 1,842
05/09/2019 Michael Bell
Chief Financial Officer
937   Derivative/Non-derivative trans. at $5.9 per share. 5,528
05/09/2019 Michael Bell
Chief Financial Officer
139   Derivative/Non-derivative trans. at $2.8 per share. 389
05/09/2019 Michael Bell
Chief Financial Officer
833   Derivative/Non-derivative trans. at $1 per share. 833
05/03/2019 Sasha King
Chief Commercial Officer
1,250   Disposition at $29.5 per share. 36,875
05/03/2019 Sasha King
Chief Commercial Officer
417   Derivative/Non-derivative trans. at $6.31 per share. 2,631
05/03/2019 Sasha King
Chief Commercial Officer
833   Derivative/Non-derivative trans. at $5.9 per share. 4,914

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
36 Purchases
14 Sales
111,200
238,780
Last 6 months
76 Purchases
37 Sales
585,447
606,625
Last 12 months
96 Purchases
49 Sales
792,401
893,938

Officers and Executives

Dr. Reginald Seeto
President & Chief Business Officer
Dr. Peter K. Maag
Chief Executive Officer & Director
Mr. Paul Ciccolella
Senior Vice President-Global Operations
Mr. Michael Bell
Chief Financial & Principal Accounting Officer
Dr. James P. Yee
Chief Medical Officer & Executive Vice President
Dr. Robert N. Woodward
Vice President-Research & Development
Ms. Sasha King
Chief Commercial Officer
Mr. Anders Eric Karlsson
Chief International Business Officer
Dr. Grace E. Colón
Director
Ms. Marissa Dixon
Vice President-Human Resources
Mr. Michael D. Goldberg
Independent Chairman
Dr. Ralph D. Snyderman
Independent Director
Dr. Fred E. Cohen
Independent Director
Mr. William A. Hagstrom
Independent Director
Mr. George W. Bickerstaff
Independent Director
Link to MarketWatch's Slice.